ophthalmology Archives - Pharmaphorum

Bayer begins phase 3 trial testing aflibercept in infant blindness

https://pharmaphorum.com/news/bayer-begins-phase-3-trial-testing-aflibercept-in-infant-blindness/

Registration opens for SMi’s 3rd Annual Ophthalmic Drugs Conference

https://pharmaphorum.com/partner-content/registration-opens-for-smis-3rd-annual-ophthalmic-drugs-conference/

NICE backs Alimera’s three-year uveitis implant

https://pharmaphorum.com/news/nice-backs-alimeras-three-year-uveitis-implant/

Ophthalmic Drugs Conference

https://pharmaphorum.com/events/ophthalmic-drugs-conference/

Novartis shows off pipeline – including 25 potential blockbusters

https://pharmaphorum.com/news/novartis-shows-off-pipeline-including-25-potential-blockbusters/

Ping An completes trial of AI-based retinal disease screening system

https://pharmaphorum.com/news/ping-an-completes-trial-of-ai-based-retinal-disease-screening-system/

J&J unveils top pipeline prospects, with main focus on cancer

https://pharmaphorum.com/news/jj-unveils-top-pipeline-prospects-cancer/

FDA approves Regeneron’s Eylea for diabetic retinopathy

https://pharmaphorum.com/news/fda-approves-regenerons-eylea-for-diabetic-retinopathy/

Takeda to sell dry eye drug to Novartis for up to $5.3bn

https://pharmaphorum.com/news/takeda-to-sell-dry-eye-drug-to-novartis-for-up-to-5-3bn/

Search